Literature DB >> 17544408

Contributions of Zn(II)-binding to the structural stability of endostatin.

Qing Han1, Yan Fu, Hao Zhou, Yingbo He, Yongzhang Luo.   

Abstract

Endostatin has a compact structure with a Zn(II)-binding site (His1, His3, His11, and Asp76) at the N-terminus. In this study, the effects of Zn(II)-binding on the folding and stability of recombinant human endostatin were studied. The results show that Zn(II)-binding largely stabilizes the structure of endostatin at physiological pH. Under some proteolytic conditions, Zn(II)-binding also contributes to the integrity of the N-terminus of endostatin, which is critical for endostatin to maintain a stable structure. Moreover, engineering an extra Zn(II)-binding peptide to the N-terminus of human endostatin makes this molecule more stable and cooperative in the presence of Zn(II).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17544408     DOI: 10.1016/j.febslet.2007.05.058

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Endostar inhibits ascites formation and prolongs survival in mouse models of malignant ascites.

Authors:  Hongmei Wei; Shukui Qin; Xiaojin Yin; Yali Chen; Haiqing Hua; Lin Wang; Ningrong Yang; Yingxia Chen; Xiufeng Liu
Journal:  Oncol Lett       Date:  2015-04-21       Impact factor: 2.967

2.  Hepatic epithelioid hemangioendothelioma after thirteen years' follow-up: A case report and review of literature.

Authors:  Wei-Fang Mo; Yu-Ling Tong
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

Review 3.  Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.

Authors:  Amit Walia; Jessica F Yang; Yu-Hui Huang; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Biochim Biophys Acta       Date:  2015-09-12

4.  Iron binding effects on the kinetic stability and unfolding energetics of a thermophilic phenylalanine hydroxylase from Chloroflexus aurantiacus.

Authors:  Angel Luis Pey; Aurora Martinez
Journal:  J Biol Inorg Chem       Date:  2009-01-20       Impact factor: 3.358

5.  Incidence and clinical implication of tumor cavitation in patients with advanced non-small cell lung cancer induced by Endostar, an angiogenesis inhibitor.

Authors:  Chun Huang; Xuan Wang; Jing Wang; Li Lin; Zhujun Liu; Wenjing Xu; Liuchun Wang; Jianyu Xiao; Kai Li
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

Review 6.  The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering.

Authors:  Abbas Mohajeri; Sarvin Sanaei; Farhad Kiafar; Amir Fattahi; Majid Khalili; Nosratollah Zarghami
Journal:  Adv Pharm Bull       Date:  2017-04-13

Review 7.  Endostatin in fibrosis and as a potential candidate of anti-fibrotic therapy.

Authors:  Zequn Zhang; Xi Liu; Zhaolong Shen; Jun Quan; Changwei Lin; Xiaorong Li; Gui Hu
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

8.  Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.

Authors:  Seung-Uon Shin; Hyun-Mi Cho; Rathin Das; Hava Gil-Henn; Sundaram Ramakrishnan; Ahmed Al Bayati; Stephen F Carroll; Yu Zhang; Ankita P Sankar; Christian Elledge; Augustin Pimentel; Marzenna Blonska; Joseph D Rosenblatt
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

9.  Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog.

Authors:  Shan Wang; Yan Fu; Yongzhang Luo
Journal:  Chin J Cancer       Date:  2016-01-20

10.  Analysis of Procollagen C-Proteinase Enhancer-1/Glycosaminoglycan Binding Sites and of the Potential Role of Calcium Ions in the Interaction.

Authors:  Jan Potthoff; Krzysztof K Bojarski; Gergely Kohut; Agnieszka G Lipska; Adam Liwo; Efrat Kessler; Sylvie Ricard-Blum; Sergey A Samsonov
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.